NEW YORK (GenomeWeb) – The European Commission has granted conditional clearance of Merck KGaA's planned acquisition of Sigma-Aldrich, the firms said today.

To satisfy the conditions for clearance by the EC, the firms agreed that Sigma-Aldrich would sell parts of its solvents and inorganics chemicals business in the European Economic Area as a fully integrated, standalone business.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.